TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Ekman Biomedical Data AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
1,040
|
389
|
86 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-307
|
144
|
-1 |
| EBITDA |
-330
|
126
|
-2 |
| Total assets |
1,158
|
1,261
|
981 |
| Current assets |
1,158
|
1,261
|
981 |
| Current liabilities |
300
|
116
|
18 |
| Equity capital |
858
|
1,145
|
963 |
| - share capital |
103
|
101
|
95 |
| Employees (average) |
1
|
0
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
74.1%
|
90.8%
|
98.2% |
| Turnover per employee | 1,040 | 86 | |
| Profit as a percentage of turnover |
-29.5%
|
37.0%
|
-1.2% |
| Return on assets (ROA) |
-26.5%
|
11.4%
|
-0.1% |
| Current ratio |
386.0%
|
1087.1%
|
5450.0% |
| Return on equity (ROE) |
-35.8%
|
12.6%
|
-0.1% |
| Change turnover |
644
|
297
|
51 |
| Change turnover % |
163%
|
322%
|
146% |
| Chg. No. of employees |
1
|
-1
|
0 |
| Chg. No. of employees % |
-100%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.